Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Joan Finch"'
Autor:
Celia Darland, Stephen A. Harrison, Amy Webb, Jean Hardies, Kenneth Cusi, Amalia Gastaldelli, Fermin O. Tio, Joan Finch, Romina Lomonaco, Carolina Ortiz-Lopez, Beverly Orsak
Publikováno v:
Hepatology. 55:1389-1397
The role of adipose tissue insulin resistance in the pathogenesis of nonalcoholic fatty liver disease (NAFLD) remains unclear. To evaluate this, we measured in 207 patients with NAFLD (age = 51 ± 1, body mass index = 34.1 ± 0.3 kg/m2) and 22 contro
Autor:
Joan Finch, Beverly Orsak, Romina Lomonaco, Kenneth Cusi, Christopher Louden, Carolina Ortiz-Lopez, Amy Webb, Fermin O. Tio, Fernando Bril
Publikováno v:
Hepatology. 54:837-845
The role of ethnicity in determining disease severity in nonalcoholic steatohepatitis (NASH) remains unclear. We recruited 152 patients with biopsy-proven NASH, 63% of whom were Hispanic and 37% of whom were Caucasian. Both groups were well matched f
Publikováno v:
Pancreas. 29:243-245
Autor:
Jean Hardies, Kenneth Cusi, Valeria G. Kochunov, Carolina Ortiz-Lopez, Beverly Orsak, Zhi Chang, Romina Lomonaco, Joan Finch
Publikováno v:
Diabetes Care
OBJECTIVE Prediabetes and type 2 diabetes mellitus (T2DM) are believed to be common and associated with a worse metabolic profile in patients with nonalcoholic fatty liver disease (NAFLD). However, no previous study has systematically screened this p
Autor:
Celia Darland, Amalia Gastaldelli, Renata Belfort, Steven Schenker, Joan Finch, Kenneth Cusi, Bogdan Balas, Stephen A. Harrison
Publikováno v:
Journal of hepatology. 47(4)
Non-Alcoholic Steatohepatitis (NASH) is a chronic liver disease frequently associated with insulin resistance and type 2 diabetes mellitus (T2DM). Pioglitazone reverses the metabolic and histological abnormalities of patients with impaired glucose to
Autor:
Stephen A. Harrison, Chris Fincke, Jean Hardies, Celia Darland, Amalia Gastaldelli, Ralph A. DeFronzo, Bogdan Balas, Joseph P. Pulcini, Sunil Dwivedi, Rachele Berria, Joan Finch, Kenneth Cusi, Russell Havranek, Fermin O. Tio, George A. Bannayan, Jennie Z. Ma, Renata Belfort, Steven Schenker, Kenneth A. Brown
Publikováno v:
The New England journal of medicine. 355(22)
BACKGROUND No pharmacologic therapy has conclusively proved to be effective for the treatment of nonalcoholic steatohepatitis, which is characterized by insulin resistance, steatosis, and necroinflammation with or without centrilobular fibrosis. Piog
Autor:
Joan Finch, Melton B. Affrime, Carlo H. Tamburro, Ronald Sabo, David L. Cutler, Steven Schenker, Michael K. Bay
Publikováno v:
Journal of interferoncytokine research : the official journal of the International Society for Interferon and Cytokine Research. 17(11)
We administered interferon-alpha2b (IFN-alpha2b) by continuous subcutaneous infusion (60,000 IU/h, or 10 million IU/week) over 3 months to 7 patients with chronic hepatitis C. All had previously responded, as assessed by normalization of transaminase
Autor:
Stephen A. Harrison, Renata Belfort, Joan Finch, Celia Darland, Kenneth Cusi, D. Ciociaro, Steven Schenker, Bogdan Balas, Amalia Gastaldelli
Publikováno v:
Journal of Hepatology. 50:S24
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.